Compare Novartis AG (NVS) vs Vanguard Growth Index Fund ETF (VUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Vanguard Growth Index Fund ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vanguard Growth Index Fund ETF trades at $86.16. The key difference: Novartis AG pays a 3.17% dividend while Vanguard Growth Index Fund ETF pays none. Which is the better fit depends on your goals.
| NVS | VUG | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Sector/Thematic |
52-Week High | $168.62 | $90.29 |
52-Week Low | $113.50 | $70.00 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Vanguard Growth Index Fund ETF
VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →
